2-Bromopyridine-3-boronic acid pinacol ester
Product Information
Molecular Formula
C11H15BBrNO2
Molecular Weight
283.96
Description
2-Bromopyridine-3-boronic acid pinacol ester is utilized in bio-medical research, widely applied in the synthesis of various pharmaceutical compounds. Specifically, it plays an essential role in drug discovery processes aiming at cardiovascular diseases and cancer treatment.
Synonyms
2-BROMO-3-PYRIDINEBORONIC ACID PINACOL ESTER; 2-BROMO-3-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-PYRIDINE; 2-BROMOPYRIDINE-3-BORONIC ACID PINACOL ESTER; 2-Bromopyridine-3-boronic acid pinacol ester, Technical, 90%; REF DUPL: 2-Bromopyridine-3-boronic a
IUPAC Name
2-bromo-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
SMILES
B1(OC(C(O1)(C)C)(C)C)C2=C(N=CC=C2)Br
InChI
InChI=1S/C11H15BBrNO2/c1-10(2)11(3,4)16-12(15-10)8-6-5-7-14-9(8)13/h5-7H,1-4H3
InChI Key
QAQDSIBZRCSYAR-UHFFFAOYSA-N
Boiling Point
353.9°C at 760mmHg
Flash Point
>230 °F
Purity
95%
Density
1.329
Appearance
Colorless to yellow liquid
Safety Information
Hazards
H315-H319-H335
Precautionary Statement
P261-P305 + P351 + P338
Computed Properties
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
3
Rotatable Bond Count
1
Exact Mass
283.03792 g/mol
Monoisotopic Mass
283.03792 g/mol
Topological Polar Surface Area
31.4Ų
Heavy Atom Count
16
Formal Charge
0
Complexity
257
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| CN-111435705-A | Repairing agent and repairing method thereof and method for preparing photoelectric film | 2019-06-12 |
| CN-112086564-A | Passivating agent and passivation method thereof and method for preparing semiconductor film | 2019-06-12 |
| WO-2020248864-A1 | Passivator, passivation method therefor and method for preparing semiconductor film | 2019-06-12 |
| TW-202003734-A | Resin composition, laminate, semiconductor wafer with resin composition layer, mounting substrate for semiconductor with resin composition layer, and semiconductor device | 2018-04-26 |
| WO-2019208614-A1 | Resin composition, laminate, resin composition layer-attached semiconductor wafer, substrate for mounting resin composition layer-attached semiconductor, and semiconductor device | 2018-04-26 |
| EP-3786200-A1 | Resin composition, laminate, resin composition layer-attached semiconductor wafer, substrate for mounting resin composition layer-attached semiconductor, and semiconductor device | 2018-04-26 |
| KR-20210004971-A | Resin composition, laminate, semiconductor wafer with resin composition layer, semiconductor mounting substrate with resin composition layer, and semiconductor device | 2018-04-26 |
| US-2021277221-A1 | Resin composition, laminate, semiconductor wafer with resin composition layer, substrate for mounting semiconductor with resin composition layer and semiconductor device | 2018-04-26 |
| JP-2014169285-A | Pharmaceuticals consisting of uracil derivatives | 2013-02-05 |
| JP-5799117-B2 | Pharmaceuticals consisting of uracil derivatives | 2013-02-05 |
